Joe Yeong(@JoeYeong) 's Twitter Profileg
Joe Yeong

@JoeYeong

MD PhD FRCPath Immunopathologist, trying to bridge two fields to impact cancerImmunotherapy and further beyond.
IMCB@A*STAR; @SingaporeGeneralHopsital.

ID:464789361

linkhttps://www.researchgate.net/profile/Joe_Yeong calendar_today15-01-2012 16:42:55

2,7K Tweets

1,3K Followers

3,2K Following

Melvin LK CHUA(@DrMLChua) 's Twitter Profile Photo

Great hosting the team from University of Michigan this morning and showcasing our Precision Radiotherapeutic Oncology Programme

Thanks for visiting Daniel Chang! Hope you enjoy your rest of the time in 🇸🇬 Weather and food are great! 😜



Great hosting the team from @UMich this morning and showcasing our Precision Radiotherapeutic Oncology Programme Thanks for visiting @Dan_ChangMD! Hope you enjoy your rest of the time in 🇸🇬 Weather and food are great! 😜 #GlobalHealth #Collaboration #RadiationOncology
account_circle
GenomeWeb(@GenomeWeb) 's Twitter Profile Photo

NanoString Customers Cautiously Optimistic About Future as Company Declares 'Not Going Away'. While some researchers are concerned about continued support of the company's products, others are more optimistic about the firm's future. ow.ly/yTfw105m8g8

account_circle
NanoString(@nanostringtech) 's Twitter Profile Photo

We thank the scientific community for the outpouring of support. With grit and tenacity for our future, we will continue to provide the same great products and customer service that we always have.

bit.ly/3IE5wUJ

account_circle
Prof. Akiko Iwasaki(@VirusesImmunity) 's Twitter Profile Photo

Delighted to share our latest work on - sex differences in symptoms and immune signatures. Led by Julio Silva Takehiro Takahashi, MD, PhD Jamie Wood et al. with Leying (Lexi) Guan & Putrino Lab. We find a striking inverse correlation btw testosterone levels and symptom burden👇🏼 (1/)…

account_circle
ASCO(@ASCO) 's Twitter Profile Photo

'Our goal is to be inclusive – we invite research ranging from real-world practice in low- or middle-income countries to clinical trials to enabling technologies and AI. - Melvin Chua, MD, PhD National Cancer Centre Singapore, Program Committee Chair, 2024 ASCO Breakthrough

account_circle
Eliza Fong, Ph.D.(@elizafongls) 's Twitter Profile Photo

Our recent work Biomaterials demonstrating use of bioengineered hydrogels to preserve patient tumor explants is featured in The Straits Times! ☺️ straitstimes.com/singapore/s-po… Gopal Iyer
sciencedirect.com/science/articl…

account_circle
Rong Fan(@RongFan8) 's Twitter Profile Photo

Looking forward to visiting Harvard University School of Engineering & Applied Science on Thursday and meeting with many old friends and making new ones 🥰🥰🥰

Single-Cell & Spatial Omics from Ice Age to Space Adventure events.seas.harvard.edu/event/single-c…

account_circle
ASCO(@ASCO) 's Twitter Profile Photo

Welcome to ASCO Breakthrough, where clinical oncology takes center stage, fueled by pioneering research and industry-shaping innovations. We invite you to be a part of this can’t-miss global meeting in Asia!

account_circle
ASCO(@ASCO) 's Twitter Profile Photo

ASCO member Dr. Melvin Chua discusses the success of 2023 ASCO Breakthrough and what he's most excited to bring attendees at !

account_circle
R. Bryan Bell, MD, DDS, FACS, FRCS(Ed)(@rbryanbell) 's Twitter Profile Photo

FDA Approves 1st Cellular Therapy to Treat Patients w Metastatic Melanoma. Testament to the vision of Dr. Steven Rosenberg & many Surgery Branch who stood on his shoulders, including our own Dr. Brendan Curti Bernard A Fox Walter J Urba MD, PhD & Eric Tran Chiles Research Institute
fda.gov/news-events/pr…

account_circle
Bernard A Fox(@BernardAFox) 's Twitter Profile Photo

💥Great news! Patients with PD-1 refractory have FDA Oncology approved option in /This treatment under development for >40 yrs (Rosenberg SA Sci 1986/NEJM 1988,Kradin R CII 1987) offers more hope to Dr. Kimryn Rathmell Melanoma Research Foundation

💥Great news! Patients with PD-1 refractory #melanoma have @FDAOncology approved #adoptive #immunotherapy option in #TIL/This treatment under development for >40 yrs (Rosenberg SA Sci 1986/NEJM 1988,Kradin R CII 1987) offers more hope to #FinishCancer @NCIDirector @CureMelanoma
account_circle
Bernard A Fox(@BernardAFox) 's Twitter Profile Photo

💥Very Proud to be a Member of the Society for of Society for Immunotherapy of Cancer⁩! It does much to improve treatments for /promotes scientific exchange across borders/educates the next generation! ⁦@gulleyj1⁩ ⁦leisha.emens⁩ sitcancer.org/yearinreview20…

account_circle
Denis Wirtz(@deniswirtz) 's Twitter Profile Photo

We have just updated our database of funding opportunities/fellowships for PhD students

For each entry of the 190 entries, we provide link, $ amount, deadline, eligibility criteria (e.g. citizenship).

Download this database for free here: research.jhu.edu/rdt/funding-op…

Good luck!

We have just updated our database of funding opportunities/fellowships for PhD students For each entry of the 190 entries, we provide link, $ amount, deadline, eligibility criteria (e.g. citizenship). Download this database for free here: research.jhu.edu/rdt/funding-op… Good luck!
account_circle
Carl June(@carlhjune) 's Twitter Profile Photo

Anti-competitive practices of 10X genomics have forced Nanostring into chapter 11 restructuring. 10x has initiated litigation against not only Nanostring but also Vizgen, Curio Biosciences and Parse Biosciences. See below for more information:
(genengnews.com/topics/biopers…)…

account_circle
Rong Fan(@RongFan8) 's Twitter Profile Photo

🤩🤩🤩 Spatial Omics fans, I am super excited to share our latest manuscript!!! 🤩🤩🤩


Spatially Exploring RNA Biology in Archival Formalin-Fixed Paraffin-Embedded Tissues
biorxiv.org/content/10.110…

account_circle